Soumya Swaminathan to head M S Swaminathan Research Foundation

Former WHO chief scientist to use science for sustainable development of rural and coastal communities

geetanjali

Geetanjali Minhas | January 31, 2023


#Soumya Swaminathan   #agriculture   #science   #policy   #WHO   #Covid-19  


Former World Health Organisation (WHO) chief scientist Soumya Swaminathan takes charge as chairperson of M S Swaminathan Research Foundation (MSSRF) from February 1.
 
Founded by her father, the legendary agricultural scientist M S Swaminathan, MSSRF was set up to accelerate the use of modern science and technology for agricultural and rural development and to improve lives and livelihoods of marginalised communities. Over 5,50,000 farm families and 2,50,000 fisherfolk from 4,000 villages across 14 states are benefitted by it every day.
 
“The pandemic has taught us that science and technology can help solve humankind’s problems but need to be used with ethics and equity as the foundation. I look forward to working with the staff of MSSRF and rural, tribal and coastal communities to use science for sustainable development,” Soumya Swaminathan said in a statement.
 
Prior to working as WHO chief scientist, she was the deputy director-general for programmes at that global health body. As the WHO’s inaugural chief scientist, she was instrumental in building its Science Division with a focus on research, quality assurance of norms and standards and digital health. During the Covid-19 pandemic, she played a key role in coordinating scientific efforts at the WHO as well as in setting up Covax with a focus on equitable vaccine distribution to LMICs.
 
Swaminathan was secretary to the Government of India for Health Research and Director General of the Indian Council of Medical Research from 2015 to 2017 where she focused on bringing science and evidence into health policy-making, building research capacity in Indian medical schools  and forging south-south partnerships in health sciences. Between 2009 to 2011 she also served as coordinator of the UNICEF/ UNDP/ World Bank/ WHO Special Programme for Research and Training in Tropical Diseases in Geneva.
 
Swaminathan has published more than 450 peer-reviewed publications and book chapters. She is a Fellow of the US National Academy of Medicine, the Academy of Medical Sciences of the UK and a Fellow of all the science academies in India. She has received several honorary doctorates, including from EPFL, Lausanne and the London School of Tropical Medicine and Hygiene. She serves on several national and global advisory bodies and committees and is an adjunct Professor at Karolinska University in Sweden and Tufts University in Boston, USA.

Comments

 

Other News

Strong El Nino threat over India`s monsoon, food & water security

India is heading into the southwest monsoon season this year under the shadow of a rapidly strengthening El Nino, with meteorologists warning that the climate phenomenon could significantly disrupt rainfall patterns, intensify heat stress and place additional pressure on the country’s agriculture-d

How corporates can nudge real change

The Business Of Business Is (Not) Just Business: How Behavioural Tools Can Drive Real Change Edited by Sutapa Banerjee, with Foreword by Nadir Godrej HarperCollins, 336 pages, Rs 699  

India stopped jailing people for paperwork. Now comes the hard part

A small pharmacist in Rajkot neglects to change a notice in his store under a little-known clause of a public health law. This was not only a non-compliance matter, but also a criminal offence, and a jail sentence was the punishment under the old system. Not a fine. Not a warning. Jail. Now scale

How to make our cities climate-resilient

Indian cities are growing at a pace that our infrastructure and climate can no longer sustain. This rapid urban sprawl increasingly strains urban systems, overshadowing the severe environmental fallout produced in its wake. The repercussions include Urban Heat Island Effect (UHI), Urban Floods, and many mo

Trump’s China setback pushes US to woo India

A week after Donald Trump’s visit to China – the first by an American president in nine years, US secretary of state Marco Rubio arrived in India on May 23 on a four-day visit aimed at resetting Washington DC’s relations with New Delhi and attending the third Quad ministerial meeting.

EU–India FTA 2026: A high‑stakes prescription for Indian pharma and healthcare

India’s pharmaceutical industry stands as one of the world’s market leaders of generic pharmacy with market valuation of USD 50 billion in 2026. Characterised by high volume, low-cost generic manufacturing, with an annual growth rate of 10-12% primarily propelled by exports and domestic demand,





Archives

Current Issue

Opinion

Facebook Twitter Google Plus Linkedin Subscribe Newsletter

Twitter